Evidence map›Paper›PMID 23825365›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2013

Endothelial Von Willebrand factor promotes blood-brain barrier flexibility and provides protection from hypoxia and seizures in mice.

Georgette L Suidan, Alexander Brill, Simon F De Meyer, Jaymie R Voorhees, Stephen M Cifuni, Jessica E Cabral, Denisa D Wagner

Open access · bronzeAbstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 86 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Modulation of the Receptor Tyrosine Kinase TIE2/International journal of molecular sciences · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Novel purine derivatives mitigate hypoxia ischemia related brain injury through agrin, zyxin and synaptotagmin proteins.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Observational
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Georgette L SuidanImmune Disease Institute, Boston, MA, USA.
Alexander Brill
Simon F De Meyer
Jaymie R Voorhees
Stephen M Cifuni
Jessica E Cabral
Denisa D Wagner
Harvard University · US

Funding

WEIBEL-PALADE BODY FORMATION AND ROLE IN HEMOSTASISR01HL041002 · NHLBI · TUFTS MEDICAL CENTER · PI WAGNER, DENISA D · 1988 to 2013
$2.0M
The role of VWF and platelets in BBB alterations associated with hypoxiaF32NS073245 · NINDS · IMMUNE DISEASE INSTITUTE, INC. · PI SUIDAN, GEORGETTE LEILA · 2011 to 2013
$116k
NHLBI NIH HHS R01 HL041002NINDS NIH HHS 1F32NS073245NINDS NIH HHS F32 NS073245
6 · The paper itself

Abstract

objectiveAberrant blood-brain barrier (BBB) permeability is a hallmark pathology of many central nervous system diseases. von Willebrand factor (VWF) is stored in endothelial Weibel-Palade bodies from where it is released on activation into plasma and basement membrane. The role of VWF in endothelial homeostasis is unclear. The goal of this study was to assess the role of VWF in disease models associated with increased BBB permeability. APPROACH AND

resultsWe did not find any differences in BBB permeability to Evans blue dye at baseline between wild-type and VWF(-/-) animals. We next used 2 models presenting with increased BBB permeability, hypoxia/reoxygenation and pilocarpine-induced status epilepticus, to assess the response of VWF(-/-) animals. In both models, VWF(-/-) mice maintained a tighter BBB than wild-type mice. VWF(-/-) mice fared worse in both conditions, with ≈ 100% of VWF(-/-) mice dying within 120 minutes after pilocarpine administration, whereas >80% of wild-type animals survived. Investigation into the status of tight junction proteins revealed that VWF(-/-) mice expressed more claudin-5 at baseline. In vitro work confirmed that the presence of subendothelial VWF is inhibitory to claudin-5 expression.

conclusionsVWF deficiency confers partial preservation of BBB integrity after hypoxia/reoxygenation and seizures. Surprisingly, this decrease in BBB permeability did not result in protection of animals because they demonstrated more severe pathology in both models compared with wild-type animals. These data suggest that a rigid BBB is detrimental (to the organism) during certain disease states and that VWF release may provide desired flexibility under stress.

Indexed as

Capillary PermeabilityAnimalsBlood-Brain BarrierCells, CulturedClaudin-5Disease Models, AnimalEndothelial CellsFemaleGenotypeHypoxia-Ischemia, BrainMaleMiceMice, Inbred C57BLMice, KnockoutPhenotypePilocarpineClaudin-5Cldn5 protein, mousePilocarpineRecombinant Proteinsvon Willebrand Factorblood–brain barrierblood vesselsclaudin-5endotheliumhypoxiaseizuresvon Willebrand factor

Identifiers

PMID23825365
PMCPMC3854012
OpenAlexW2166351341

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.